Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Service coverage for major depressive disorder: estimated rates of minimally adequate treatment for 204 countries and territories in 2021

Open access

Abstract

BACKGROUND: Access to effective treatment for major depressive disorder remains limited and difficult to track across place and time. We analysed the available data on minimally adequate treatment (MAT) for major depressive disorder globally with the aim of providing a useful metric against which to monitor national responses to the growing public health burden imposed by major depressive disorder. METHODS: MAT was defined as pharmacotherapy (1 month of medication, plus four visits to a medical doctor) or psychotherapy (eight visits with any professional). From existing reviews, we identified mental health surveys that assessed major depressive disorder within the general population as well as health service uptake by individuals with major depressive disorder. Data by ethnicity were not available. Estimates of MAT, antidepressant use, or use of any mental health service were extracted. The latter two estimates were adjusted to reflect likely MAT rates via a network meta-analysis. Adjusted MAT estimates were analysed via a Bayesian meta-regression using the Disease Modelling Meta-Regression (DisMod-MR 2.1) tool. This analysis estimated MAT coverage among people with major depressive disorder by age, sex, location, and year. Final MAT estimates were standardised by age and sex against the existing age and sex distribution of people with major depressive disorder globally. People with lived experience were involved in the design, preparation, interpretation, and writing of this manuscript. FINDINGS: The analysed dataset included 145 estimates from 32 studies, covering 31 countries, 14 regions, and six super-regions. The proportion of people with major depressive disorder receiving MAT globally in 2021 was 9·1% (95% uncertainty interval 7·2-11·6), with 10·2% (8·2-13·1) of females and 7·2% (5·7-9·3) of males with major depressive disorder receiving MAT. MAT coverage was highest in high-income locations (27·0% [21·7-34·4]), with Australasia having the highest rate (29·2% [21·4-40·8]). MAT coverage was lowest in sub-Saharan Africa (2·0% [1·5-2·6]), within which western sub-Saharan Africa (1·8% [1·4-2·5]) had the lowest coverage. Seven countries (Australia, Belgium, Canada, Germany, the Netherlands, South Korea, and Sweden) were estimated to have MAT coverage exceeding 30%, while 90 countries were estimated to have coverage lower than 5%. INTERPRETATION: Despite many gaps in the available data, estimates show that, globally, most individuals with major depressive disorder do not receive MAT. Services must improve to reach a global coverage that better meets the mental health needs of those with major depressive disorder. Urgent attention should be given to the scale-up of effective intervention strategies, especially in low-income and middle-income countries, as well as further research into better quality treatment options for major depressive disorder. We present a means by which the MAT gap for major depressive disorder can be quantified, to monitor and inform action by governments and international partners. FUNDING: Queensland Health and the Bill & Melinda Gates Foundation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2215-0366(24)00317-1

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The number of sources per country used to inform the estimation of minimally adequate treatment The geographical delineations presented in this figure are in accordance with WHO standards and differ from the geographical hierarchy used in the statistical analyses. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.
Figure 1 The number of sources per country used to inform the estimation of minimally adequate treatment The geographical delineations presented in this figure are in accordance with WHO standards and differ from the geographical hierarchy used in the statistical analyses. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.CC BY · PubMed Central
Figure 2 Global prevalence of major depressive disorder and rate of minimally adequate treatment coverage for major depressive disorder per 100 000 people by sex, 2021 Whiskers show 95% uncertainty intervals.
Figure 2 Global prevalence of major depressive disorder and rate of minimally adequate treatment coverage for major depressive disorder per 100 000 people by sex, 2021 Whiskers show 95% uncertainty intervals.CC BY · PubMed Central
Figure 3 The proportion of people with major depressive disorder receiving minimally adequate treatment by country, 2021 The geographical delineations presented in this figure are in accordance with WHO standards and differ from the geographical hierarchy used in the statistical analyses. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.
Figure 3 The proportion of people with major depressive disorder receiving minimally adequate treatment by country, 2021 The geographical delineations presented in this figure are in accordance with WHO standards and differ from the geographical hierarchy used in the statistical analyses. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 57

Metadata

Authors
Santomauro, D. F., Vos, T., Whiteford, H. A., Chisholm, D., Saxena, S., & Ferrari, A. J.
Affiliations
  • The University of Queensland (AU)
  • University of Washington (US)
  • World Health Organization (CH)
  • Harvard University (US)
Corresponding author
Santomauro, Damian F
Venue
The Lancet Psychiatry
Publisher
Elsevier BV
Published
2024-12
Volume
11
Issue
12
Pages
1012-1021
ISSN
2215-0366 (ISSN-L)
OpenAlex
W4404514335
Cited by
57
References
22
Citations by year
2026: 39 · 2025: 17 · 2024: 1
FWCI
26.95
Type
journal article
Language
en
Update notices
erratum (2025-01-01)
Open access
Licence
Locations
  • The Lancet Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Bill & Melinda Gates Foundation
  • Queensland Health
  • Queensland Government
  • Tasmanian Department of Health
  • World Health Organization
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
Keywords
major depressive disorder, treatment coverage, antidepressant use, psychotherapy, mental health service utilization, global mental health, sub-Saharan Africa, sex differences in treatment, high-income countries, low-income countries, Bayesian meta-regression, lived experience of mental illness, mental health professionals, mental health funding
MeSH terms
Adolescent, Adult, Aged, Antidepressive Agents, Bayes Theorem, Major Depressive Disorder, Female, Health Services Accessibility, Humans, Male, Mental Health Services, Middle Aged, Psychotherapy, Global Health, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Service coverage for major depressive disorder: estimated rates of minimally adequate treatment for 204 countries and territories in 2021. https://app.cochat.ai/papers/10.1016/s2215-0366(24)00317-1
The paper
Santomauro, D. F., Vos, T., Whiteford, H. A., Chisholm, D., Saxena, S., & Ferrari, A. J. (2024). Service coverage for major depressive disorder: estimated rates of minimally adequate treatment for 204 countries and territories in 2021. The Lancet Psychiatry. https://doi.org/10.1016/s2215-0366(24)00317-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.